---
title: "Lilly rounds out oral GLP-1 approval bid with phase 3 obesity win for patients with diabetes"
date: 2025-08-27T18:57:38.440Z
source: "fiercebiotech.com"
source_url: https://www.fiercebiotech.com/biotech/lilly-rounds-out-oral-glp-1-approval-bid-ph-3-win-patients-obesity-and-diabetes
---

## Shrnutí (CZ)
After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s chances of securing a green light in obesity.

---

[Otevřít zdroj](https://www.fiercebiotech.com/biotech/lilly-rounds-out-oral-glp-1-approval-bid-ph-3-win-patients-obesity-and-diabetes)
